ArticleJournal of clinical pharmacology2018

Single-Center Evaluation of the Pharmacokinetics and Safety of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Mild to Moderate Hepatic Impairment.

Caroline Dudkowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.